Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation

European Neuropsychopharmacology

Volumn 27, Issue 6, 2017, Pages 554-559

  Pariante, Carmine M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antidepressants; Childhood trauma; Glucocorticoid receptor; HPA; Immunopsychiatry; mRNA; Psychoneuroimmunology.

Indexed keywords

BIOLOGICAL MARKER; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; ANTIINFLAMMATORY AGENT; AUTACOID; HYDROCORTISONE;

CELLS; DEPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; MEDICAL RESEARCH; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; DEFICIENCY; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INBORN ERROR OF METABOLISM; METABOLISM; PSYCHOLOGY; TIME FACTOR; TRENDS;

ANTI-INFLAMMATORY AGENTS; BIOMEDICAL RESEARCH; DEPRESSION; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; INFLAMMATION MEDIATORS; METABOLISM, INBORN ERRORS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID; TIME FACTORS;

EID: 85018795239     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2017.04.001     Document Type: Review

References (49)

1. Alboni, S., Gibellini, L., Montanari, C., Benatti, C., Benatti, S., Tascedda, F., Brunello, N., Cossarizza, A., Pariante, C.M., N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-α in human neurons. Int. J. Neuropsychopharmacol. 16:8 (2013), 1849–1865.
2. Anacker, C., Cattaneo, A., Luoni, A., Musaelyan, K., Zunszain, P.A., Milanesi, E., Rybka, J., Berry, A., Cirulli, F., Thuret, S., Price, J., Riva, M.A., Gennarelli, M., Pariante, C.M., Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. Neuropsychopharmacology. 38:5 (2013), 872–883.
3. Anacker, C., Cattaneo, A., Musaelyan, K., Zunszain, P.A., Horowitz, M., Molteni, R., Luoni, A., Calabrese, F., Tansey, K., Gennarelli, M., Thuret, S., Price, J., Uher, R., Riva, M.A., Pariante, C.M., Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. Proc. Natl. Acad. Sci. USA 110:21 (2013), 8708–8713.
4. Anacker, C., Zunszain, P.A., Cattaneo, A., Carvalho, L.A., Garabedian, M.J., Thuret, S., Price, J., Pariante, C.M., Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol. Psychiatry 16:7 (2011), 738–750.
5. Barnes, J., Mondelli, V., Pariante, C.M., Genetic contributions of inflammation to depression. Neuropsychopharmacology 42:1 (2017), 81–98.
6. Bartoloni, C., Guidi, L., Antico, L., Pariante, C.M., Di Giovanni, A., Pili, R., Cursi, F., Tricerri, A., Tempesta, E., Frasca, D., et al. Psychological status and immunological parameters of institutionalized aged. Panminerva Med. 33:3 (1991), 164–169.
7. Baumeister, D., Akhtar, R., Ciufolini, S., Pariante, C.M., Mondelli, V., Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Mol. Psychiatry 21:5 (2016), 642–649.
8. Bull, S.J., Huezo-Diaz, P., Binder, E.B., Cubells, J.F., Ranjith, G., Maddock, C., Miyazaki, C., Alexander, N., Hotopf, M., Cleare, A.J., Norris, S., Cassidy, E., Aitchison, K.J., Miller, A.H., Pariante, C.M., Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol. Psychiatry 14:12 (2009), 1095–1104.
9. Carvalho, L.A., Garner, B.A., Dew, T., Fazakerley, H., Pariante, C.M., Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms. Eur. Neuropsychopharmacol. 20:6 (2010), 379–387.
10. Carvalho, L.A., Juruena, M.F., Papadopoulos, A.S., Poon, L., Kerwin, R., Cleare, A.J., Pariante, C.M., Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression. Neuropsychopharmacology 33:13 (2008), 3182–3189.
11. Carvalho, L.A., Torre, J.P., Papadopoulos, A.S., Poon, L., Juruena, M.F., Markopoulou, K., Cleare, A.J., Pariante, C.M., Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system. J. Affect. Disord. 148:1 (2013), 136–140.
12. Cattaneo, A., Ferrari, C., Uher, R., Bocchio-Chiavetto, L., Riva, M.A., MRC ImmunoPsychiatry Consortium, Pariante, C.M., Absolute measurements of macrophage migration inhibitory factor and interleukin-1-β mRNA levels accurately predict treatment response in depressed patients. Int. J. Neuropsychopharmacol., 19, 2016, 10.
13. Cattaneo, A., Gennarelli, M., Uher, R., Breen, G., Farmer, A., Aitchison, K.J., Craig, I.W., Anacker, C., Zunsztain, P.A., McGuffin, P., Pariante, C.M., Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline ׳predictors׳ and longitudinal ׳targets׳. Neuropsychopharmacology 38:3 (2013), 377–385.
14. Danese, A., Caspi, A., Williams, B., Ambler, A., Sugden, K., Mika, J., Werts, H., Freeman, J., Pariante, C.M., Moffitt, T.E., Arseneault, L., Biological embedding of stress through inflammation processes in childhood. Mol. Psychiatry 16:3 (2011), 244–246.
15. Danese, A., Moffitt, T.E., Harrington, H., Milne, B.J., Polanczyk, G., Pariante, C.M., Poulton, R., Caspi, A., Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch. Pediatr. Adolesc. Med. 163:12 (2009), 1135–1143.
16. Danese, A., Moffitt, T.E., Pariante, C.M., Ambler, A., Poulton, R., Caspi, A., Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch. Gen. Psychiatry 65:4 (2008), 409–415.
17. Danese, A., Pariante, C.M., Caspi, A., Taylor, A., Poulton, R., Childhood maltreatment predicts adult inflammation in a life-course study. Proc. Natl. Acad. Sci. USA 104:4 (2007), 1319–1324.
18. Di Nicola, M., Cattaneo, A., Hepgul, N., Di Forti, M., Aitchison, K.J., Janiri, L., Murray, R.M., Dazzan, P., Pariante, C.M., Mondelli, V., Serum and gene expression profile of cytokines in first-episode psychosis. Brain Behav. Immun. 31 (2013), 90–95.
19. Du Preez, A., Leveson, J., Zunszain, P.A., Pariante, C.M., Inflammatory insults and mental health consequences: does timing matter when it comes to depression?. Psychol. Med. 46:10 (2016), 2041–2057.
20. Handley, R., Mondelli, V., Zelaya, F., Marques, T., Taylor, H., Reinders, A.A., Chaddock, C., McQueen, G., Hubbard, K., Papadopoulos, A., Williams, S., McGuire, P., Pariante, C., Dazzan, P., Effects of antipsychotics on cortisol, interleukin-6 and hippocampal perfusion in healthy volunteers. Schizophr. Res. 174:1-3 (2016), 99–105.
21. Hepgul, N., Cattaneo, A., Agarwal, K., Baraldi, S., Borsini, A., Bufalino, C., Forton, D.M., Mondelli, V., Nikkheslat, N., Lopizzo, N., Riva, M.A., Russell, A., Hotopf, M., Pariante, C.M., Transcriptomics in interferon-α-treated patients identifies inflammation-, neuroplasticity- and oxidative stress-related signatures as predictors and correlates of depression. Neuropsychopharmacology 41:10 (2016), 2502–2511.
22. Hepgul, N., Cattaneo, A., Zunszain, P.A., Pariante, C.M., Depression pathogenesis and treatment: what can we learn from blood mRNA expression?. BMC Med., 11, 2013, 28.
23. Hepgul, N., Pariante, C.M., Dipasquale, S., DiForti, M., Taylor, H., Marques, T.R., Morgan, C., Dazzan, P., Murray, R.M., Mondelli, V., Childhood maltreatment is associated with increased body mass index and increased C-reactive protein levels in first-episode psychosis patients. Psychol. Med. 42:9 (2012), 1893–1901.
24. Horowitz, M.A., Wertz, J., Zhu, D., Cattaneo, A., Musaelyan, K., Nikkheslat, N., Thuret, S., Pariante, C.M., Zunszain, P.A., Antidepressant compounds can be both pro- and anti-inflammatory in human hippocampal cells. Int. J. Neuropsychopharmacol., 18, 2014, 3.
25. Mason, B.L., Pariante, C.M., Thomas, S.A., A revised role for P-glycoprotein in the brain distribution of dexamethasone, cortisol, and corticosterone in wild-type and ABCB1A/B-deficient mice. Endocrinology 149:10 (2008), 5244–5253.
26. Mason, B.L., Thomas, S.A., Lightman, S.L., Pariante, C.M., Desipramine treatment has minimal effects on the brain accumulation of glucocorticoids in P-gp-deficient and wild-type mice. Psychoneuroendocrinology 36:9 (2011), 1351–1360.
27. Mondelli, V., Cattaneo, A., Belvederi Murri, M., Di Forti, M., Handley, R., Hepgul, N., Miorelli, A., Navari, S., Papadopoulos, A.S., Aitchison, K.J., Morgan, C., Murray, R.M., Dazzan, P., Pariante, C.M., Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. J. Clin. Psychiatry 72:12 (2011), 1677–1684.
28. Mondelli, V., Ciufolini, S., Belvederi Murri, M., Bonaccorso, S., Di Forti, M., Giordano, A., Marques, T.R., Zunszain, P.A., Morgan, C., Murray, R.M., Pariante, C.M., Dazzan, P., Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis. Schizophr. Bull. 41:5 (2015), 1162–1170.
29. Nikkheslat, N., Zunszain, P.A., Horowitz, M.A., Barbosa, I.G., Parker, J.A., Myint, A.M., Schwarz, M.J., Tylee, A.T., Carvalho, L.A., Pariante, C.M., Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression. Brain Behav. Immun. 48 (2015), 8–18.
30. Pariante, C.M., Psychoneuroimmunology or immunopsychiatry?. Lancet Psychiatry 2:3 (2015), 197–199.
31. Pariante, C.M., Alhaj, H.A., Arulnathan, V.E., Gallagher, P., Hanson, A., Massey, E., McAllister-Williams, R.H., Central glucocorticoid receptor-mediated effects of the antidepressant, citalopram, in humans: a study using EEG and cognitive testing. Psychoneuroendocrinology 37:5 (2012), 618–628.
32. Pariante, C.M., Kim, R.B., Makoff, A., Kerwin, R.W., Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters. Br. J. Pharmacol. 139:6 (2003), 1111–1118.
33. Pariante, C.M., Lightman, S.L., The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 31:9 (2008), 464–468.
34. Pariante, C.M., Hye, A., Williamson, R., Makoff, A., Lovestone, S., Kerwin, R.W., The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones. Neuropsychopharmacology 28:9 (2003), 1553–1561.
35. Pariante, C.M., Makoff, A., Lovestone, S., Feroli, S., Heyden, A., Miller, A.H., Kerwin, R.W., Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br. J. Pharmacol. 134:6 (2001), 1335–1343.
36. Pariante, C.M., Miller, A.H., Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 49:5 (2001), 391–404.
37. Pariante, C.M., Papadopoulos, A.S., Poon, L., Cleare, A.J., Checkley, S.A., English, J., Kerwin, R.W., Lightman, S., Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers. Psychopharmacology 177:1–2 (2004), 200–206.
38. Pariante, C.M., Pearce, B.D., Pisell, T.L., Owens, M.J., Miller, A.H., Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mol. Pharmacol. 52:4 (1997), 571–581.
39. Pariante, C.M., Pearce, B.D., Pisell, T.L., Sanchez, C.I., Po, C., Su, C., Miller, A.H., The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 140:9 (1999), 4359–4366.
40. Pariante, C.M., Thomas, S.A., Lovestone, S., Makoff, A., Kerwin, R.W., Do antidepressants regulate how cortisol affects the brain?. Psychoneuroendocrinology 29:4 (2004), 423–447 (Review. PubMed PMID: 14749091).
41. Pawlby, S., Hay, D., Sharp, D., Waters, C.S., Pariante, C.M., Antenatal depression and offspring psychopathology: the influence of childhood maltreatment. Br. J. Psychiatry 199:2 (2011), 106–112.
42. Plant, D.T., Barker, E.D., Waters, C.S., Pawlby, S., Pariante, C.M., Intergenerational transmission of maltreatment and psychopathology: the role of antenatal depression. Psychol. Med. 43:3 (2013), 519–528.
43. Plant, D.T., Pariante, C.M., Sharp, D., Pawlby, S., Maternal depression during pregnancy and offspring depression in adulthood: role of child maltreatment. Br. J. Psychiatry 207:3 (2015), 213–220.
44. Plant, D.T., Pawlby, S., Sharp, D., Zunszain, P.A., Pariante, C.M., Prenatal maternal depression is associated with offspring inflammation at 25 years: a prospective longitudinal cohort study. Transl. Psychiatry, 6(11), 2016, e936.
45. Russell, A., Ciufolini, S., Gardner-Sood, P., Bonaccorso, S., Gaughran, F., Dazzan, P., Pariante, C.M., Mondelli, V., Inflammation and metabolic changes in first episode psychosis: preliminary results from a longitudinal study. Brain Behav. Immun. 49 (2015), 25–29.
46. Su, K.P., Huang, S.Y., Peng, C.Y., Lai, H.C., Huang, C.L., Chen, Y.C., Aitchison, K.J., Pariante, C.M., Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol. Psychiatry 67:6 (2010), 550–557.
47. Su, K.P., Lai, H.C., Yang, H.T., Su, W.P., Peng, C.Y., Chang, J.P., Chang, H.C., Pariante, C.M., Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial. Biol. Psychiatry 76:7 (2014), 559–566.
48. Yau, J.L., Noble, J., Thomas, S., Kerwin, R., Morgan, P.E., Lightman, S., Seckl, J.R., Pariante, C.M., The antidepressant desipramine requires the ABCB1 (Mdr1)-type p-glycoprotein to upregulate the glucocorticoid receptor in mice. Neuropsychopharmacology 32:12 (2007), 2520–2529.
49. Zunszain, P.A., Anacker, C., Cattaneo, A., Choudhury, S., Musaelyan, K., Myint, A.M., Thuret, S., Price, J., Pariante, C.M., Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology 37:4 (2012), 939–949.